If my treatment is not on the Cancer Drug List (CDL), will I still be covered under MediShield Life and MediSave?
MediShield Life and MediSave will only cover treatments on the Cancer Drug List (CDL) from 1 September 2022.
For Integrated Shield Plans (IPs), the CDL will only come into effect from 1 April 2023 onwards, when an existing policy is renewed, or a new policy is purchased. If you have an IP that is being renewed between 1 April 2023 and 30 September 2023, and are on a course of cancer drug treatment as of 31 March 2023, insurers have committed to preserve your current IP coverage until 30 September 2023.
Riders will cover treatments beyond the CDL, though the extent of coverage may vary. Your insurer should inform you of the details of your IP and rider coverage by end 2022.
